McCarter & English, LLP
Dihydropyrrolopyridine inhibitors of ROR-gamma
Provided are novel compounds of Formula (I):pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful in the treatment of diseases and disorders mediated by ROR. Also provided are pharmaceutical compositions comprising the novel compounds of Formula (I) and methods for their use in treating one or more inflammatory, metabolic, autoimmune and other diseases or disorders.
Vitae Pharmaceuticals, LLC
A A A A A A A A C A A A A A A A A A A A A A A A A A A A A A A A A A A A C A A
A61P A61P A61P A61P A61P A61P A61P A61P C07D A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P C07D A61P A61P
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Yajun Suresh B. Jing Colin M. Yi Stephen D. Andrew Chengguo Linghang Zhijie Lanqi Wei David A. Lawrence Wayne
Zheng Singh Yuan Tice Fan Lotesta Marcus Dong Zhuang Liu Jia Zhao Claremon Dillard